Arija, J. A., Pérez-Valderrama, B., González-Larriba, J., Rodríguez Sánchez, A., Chirivella, I., Pinto, A., Marrero, R. G., Rubio, G., García, J. J., Borrega, P., Quintela, M. L., Castellano, D., Rodríguez, C. S., García, J. M., Lambea-Sorrosal, J., Gajate, P., Fita, M. J., Puertas, J., Domínguez, R. G., & Guzmán, J. V. (n.d.). 2638 Effectiveness of 2nd-line and subsequent therapies after pazopanib (Paz) in patients (pt) with metastatic renal cell carcinoma (mRCC): Final results of the SPAZO study (SOGUG). European journal of cancer, 51, S526–. http://access.bl.uk/ark:/81055/vdc_100030628262.0x000012